What is the ticker symbol for NervGen Pharma Corp. Common stock?

NervGen Pharma Corp. Common stock trades under the ticker NGEN on NASDAQ.

What sector does NervGen Pharma Corp. Common stock operate in?

NervGen Pharma Corp. Common stock is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NGEN in a portfolio?

PortView shows NGEN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

NervGen Pharma Corp. Common stock (NGEN) Stock Analysis

NASDAQHealthcareBiotechnology

$2.36+1.51%

1-year price historyRange $1.59 – $5.97

52-week range$2.36

$1.58$6.30

What NervGen Pharma Corp. Common stock does

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300, which is in a preclinical model of ischemic stroke, amyotrophic lateral sclerosis, and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. NervGen Pharma Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Key metrics

Market cap

$193.56M

P/E (TTM)

-5.76

EPS (TTM)

$-0.41

Beta

0.71

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.85

200-day avg

$3.38

52-week high

$6.30

52-week low

$1.58

CEO

Adam H. Rogers

ETFs linked to NGEN

Broad-market and Healthcare sector ETFs an investor holding NervGen Pharma Corp. Common stock is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NGEN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NGEN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for NervGen Pharma Corp. Common stock?: NervGen Pharma Corp. Common stock trades under the ticker NGEN on NASDAQ.
Which exchange is NGEN listed on?: NGEN is listed on NASDAQ.
What sector does NervGen Pharma Corp. Common stock operate in?: NervGen Pharma Corp. Common stock is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NGEN in a portfolio?: PortView shows NGEN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.